Literature DB >> 4628259

Susceptibility of Neisseria gonorrhoeae to seven antibiotics in vitro.

H G Robson, I E Salit.   

Abstract

One hundred consecutive isolates of N. gonorrhoeae were tested for susceptibility to penicillin, ampicillin, tetracycline, erythromycin, kanamycin, cephaloridine and cephalexin by an agar dilution method. Relative resistance to penicillin was frequent. For 39% of isolates the minimum inhibitory concentration (MIC) of penicillin was 0.05 U./ml. or less; in 55% the MIC was 0.5 to 2.0 U./ml. Ampicillin was slightly more active than penicillin G: all isolates were inhibited by 0.5mug./ml. or less. Resistance to tetracycline and erythromycin was frequent with MIC of 1 mug./ml. or greater observed in 32 and 24% of isolates respectively. The MIC of kanamycin for all gonococci was 8 mug./ml. or greater. Cephalexin was slightly more active than cephaloridine, though each drug exhibited a wide range of MIC values. Gonococcus isolates resistant to penicillin (MIC of 1.0 U./ml. or greater) tended to be resistant to the other antibiotics tested.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4628259      PMCID: PMC1941007     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  9 in total

1.  Susceptibility of Neisseria gonorrhoeae to eleven antibiotics and sulfadiazine; comparison of susceptibility of recently isolated strains with results obtained in previous years in the same laboratory.

Authors:  B D LOVE; M FINLAND
Journal:  AMA Arch Intern Med       Date:  1955-01

2.  Kanamycin sulfate in the treatment of acute gonorrheal urethritis in men.

Authors:  J E Fischnaller; A H Pedersen; A R Ronald; P Bonin; E L Tronca
Journal:  JAMA       Date:  1968-03-11       Impact factor: 56.272

3.  Development of resistance of gonococci to penicillin: an eight-year study.

Authors:  C R Amies
Journal:  Can Med Assoc J       Date:  1967-01-07       Impact factor: 8.262

4.  Single oral dose ampicillin-probenecid treatment of gnorrhea in the male.

Authors:  P A Kvale; T F Keys; D W Johnson; K K Holmes
Journal:  JAMA       Date:  1971-03-01       Impact factor: 56.272

5.  The use of cephalexin in the treatment of gonorrhea.

Authors:  C F Ackman; E C Reid; Y Homsy
Journal:  Can Med Assoc J       Date:  1972-02-19       Impact factor: 8.262

6.  A study of the relationships between the sensitivities of Neisseria gonorrhoeae to sodium penicillin G, four semi-synthetic penicillins, spiramycin, and fusidic acid.

Authors:  A Reyn; M W Benzon
Journal:  Br J Vener Dis       Date:  1968-06

7.  Comparative study of gonococcal susceptibility to penicillin in the United States, 1955-1969.

Authors:  J E Martin; A Lester; E V Price; J D Schmale
Journal:  J Infect Dis       Date:  1970-11       Impact factor: 5.226

8.  Single-dose treatment of gonorrhea with selected antibiotic agents.

Authors:  T F Keys; C W Halverson; E J Clarke
Journal:  JAMA       Date:  1969-11-03       Impact factor: 56.272

9.  Surveillance studies on Neisseria gonorrhoea sensitivity to penicillin and nine other antibiotics.

Authors:  J D THAYER; F W FIELD; M I PERRY; J E MARTIN; W GARSON
Journal:  Bull World Health Organ       Date:  1961       Impact factor: 9.408

  9 in total
  12 in total

1.  In-vitro activity of antimicrobial agents against Neisseria gonorrhoeae in Brussels.

Authors:  R Vanhoof; M P Vanderlinden; J M Hubrechts; J P Butzler; E Yourassowsky
Journal:  Br J Vener Dis       Date:  1978-10

2.  Gonococcal opacity variants: susceptibility to antimicrobial agents.

Authors:  I E Salit; M Bond
Journal:  Antimicrob Agents Chemother       Date:  1982-09       Impact factor: 5.191

3.  Increased susceptibility of Neisseria gonorrhoea from a rural area.

Authors:  D W Gump; P T Berry
Journal:  Antimicrob Agents Chemother       Date:  1973-04       Impact factor: 5.191

4.  Cefoperazone (Cefobid) for treating men with gonorrhoea caused by penicillinase producing Neisseria gonorrhoeae.

Authors:  J H Kim; Y S Ro; Y T Kim
Journal:  Br J Vener Dis       Date:  1984-08

5.  Patients' compliance with follow-up after treatment of gonococcal urethritis.

Authors:  R W Mitchell; H G Robson
Journal:  Can Med Assoc J       Date:  1977-01-08       Impact factor: 8.262

6.  Cross-Canada survey of susceptibility of Neisseria gonorrhoeae isolates to six antimicrobial agents.

Authors:  J R Dillon; L Eidus; B B Diena
Journal:  Can Med Assoc J       Date:  1978-08-12       Impact factor: 8.262

7.  In-vitro activity of 21 antimicrobial agents against Neisseria gonorrhoeae in Brussels.

Authors:  B Gordts; R Vanhoof; J M Hubrechts; R Dierickx; H Coignau; J P Butzler
Journal:  Br J Vener Dis       Date:  1982-02

8.  Treatment of gonorrheal urethritis with spectinomycin hydrochloride.

Authors:  J Brown; O Tabert; J D Hanna; P L Rentiers
Journal:  Can Med Assoc J       Date:  1974-01-19       Impact factor: 8.262

9.  Antibiotic sensitivities of Neisseria gonorrhoeae in the Toronto area.

Authors:  K F Givan; A Keyl
Journal:  Can Med Assoc J       Date:  1974-07-06       Impact factor: 8.262

10.  Single-dose treatment of gonococcal urethritis in males: evaluation of procaine penicillin, ampicillin and spectinomycin.

Authors:  R W Mitchell; H G Robson
Journal:  Can Med Assoc J       Date:  1974-01-19       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.